These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9442056)

  • 1. High resolution crystal structure of a human tumor necrosis factor-alpha mutant with low systemic toxicity.
    Cha SS; Kim JS; Cho HS; Shin NK; Jeong W; Shin HC; Kim YJ; Hahn JH; Oh BH
    J Biol Chem; 1998 Jan; 273(4):2153-60. PubMed ID: 9442056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human tumor necrosis factor mutants with preferential binding to and activity on either the R55 or R75 receptor.
    Van Ostade X; Vandenabeele P; Tavernier J; Fiers W
    Eur J Biochem; 1994 Mar; 220(3):771-9. PubMed ID: 8143731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-directed mutational analysis of human tumor necrosis factor-alpha receptor binding site and structure-functional relationship.
    Zhang XM; Weber I; Chen MJ
    J Biol Chem; 1992 Nov; 267(33):24069-75. PubMed ID: 1331108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of TNF-alpha mutant R31D with greater affinity for receptor R1 compared with R2.
    Reed C; Fu ZQ; Wu J; Xue YN; Harrison RW; Chen MJ; Weber IT
    Protein Eng; 1997 Oct; 10(10):1101-7. PubMed ID: 9488135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function relationship of tumor necrosis factor (TNF) and its receptor interaction based on 3D structural analysis of a fully active TNFR1-selective TNF mutant.
    Mukai Y; Shibata H; Nakamura T; Yoshioka Y; Abe Y; Nomura T; Taniai M; Ohta T; Ikemizu S; Nakagawa S; Tsunoda S; Kamada H; Yamagata Y; Tsutsumi Y
    J Mol Biol; 2009 Jan; 385(4):1221-9. PubMed ID: 19084540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creation and X-ray structure analysis of the tumor necrosis factor receptor-1-selective mutant of a tumor necrosis factor-alpha antagonist.
    Shibata H; Yoshioka Y; Ohkawa A; Minowa K; Mukai Y; Abe Y; Taniai M; Nomura T; Kayamuro H; Nabeshi H; Sugita T; Imai S; Nagano K; Yoshikawa T; Fujita T; Nakagawa S; Yamamoto A; Ohta T; Hayakawa T; Mayumi T; Vandenabeele P; Aggarwal BB; Nakamura T; Yamagata Y; Tsunoda S; Kamada H; Tsutsumi Y
    J Biol Chem; 2008 Jan; 283(2):998-1007. PubMed ID: 18003610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the limited trypsinolysis pathways of tumor necrosis factor-alpha and its mutant by electrospray ionization mass spectrometry.
    Kim YJ; Cha SS; Kim JS; Shin NK; Jeong W; Shin HC; Oh BH; Hahn JH
    Anal Biochem; 1999 Feb; 267(2):279-86. PubMed ID: 10036131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel tumor necrosis factor-alpha mutant with significantly enhanced cytotoxicity and receptor binding affinity.
    Shin NK; Lee I; Chang SG; Shin HC
    Biochem Mol Biol Int; 1998 May; 44(6):1075-82. PubMed ID: 9623760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor mutants with selective cytotoxic activity.
    Berkova N; Lemay A; Korobko V; Shingarova L; Sagaidak L; Goupil S
    Cancer Detect Prev; 1999; 23(1):1-7. PubMed ID: 9892984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human TNF mutants with selective activity on the p55 receptor.
    Van Ostade X; Vandenabeele P; Everaerdt B; Loetscher H; Gentz R; Brockhaus M; Lesslauer W; Tavernier J; Brouckaert P; Fiers W
    Nature; 1993 Jan; 361(6409):266-9. PubMed ID: 8380906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel recombinant tumor necrosis factor-alpha mutant with increased anti-tumor activity and lower toxicity.
    Nakamura S; Kato A; Masegi T; Fukuoka M; Kitai K; Ogawa H; Ichikawa Y; Maeda M; Watanabe N; Kohgo Y
    Int J Cancer; 1991 Jul; 48(5):744-8. PubMed ID: 1649139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of gene transfer of tumor necrosis factor receptors into human lung carcinoma cell line.
    Ohara H; Hasegawa Y; Kawabe T; Ichiyama S; Hara T; Shimono Y; Saito H; Shimokata K
    Jpn J Cancer Res; 1998 May; 89(5):589-95. PubMed ID: 9685865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological activities of human tumor necrosis factor-alpha and its novel mutants.
    Xi T; Shi X; Guo D; Dong X; Xu X; Zhu D
    Biochem Mol Biol Int; 1996 Apr; 38(4):855-62. PubMed ID: 8728116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An apoptosis-inducing gene therapy for pancreatic cancer with a combination of 55-kDa tumor necrosis factor (TNF) receptor gene transfection and mutein TNF administration.
    Sato T; Yamauchi N; Sasaki H; Takahashi M; Okamoto T; Sakamaki S; Watanabe N; Niitsu Y
    Cancer Res; 1998 Apr; 58(8):1677-83. PubMed ID: 9563482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between novel tumor necrosis factor-alpha mutants and receptors on tumor and normal cells.
    Nakamura S; Masegi T; Fukuoka M; Kitai K; Kato A; Ichikawa Y; Watanabe N; Niitsu Y
    Agric Biol Chem; 1991 Jan; 55(1):53-7. PubMed ID: 1369315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential responses of fibroblasts from wild-type and TNF-R55-deficient mice to mouse and human TNF-alpha activation.
    Mackay F; Rothe J; Bluethmann H; Loetscher H; Lesslauer W
    J Immunol; 1994 Dec; 153(11):5274-84. PubMed ID: 7525730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological activities of human tumor necrosis factor-alpha and its novel mutants.
    Xi T; Shi X; Guo D; Dong X; Xu X; Zhu D
    Biochem Mol Biol Int; 1996 May; 38(6):1183-9. PubMed ID: 8739040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of tumor necrosis factor (TNF) amino acids crucial for binding to the murine p75 TNF receptor and construction of receptor-selective mutants.
    Ameloot P; Fiers W; De Bleser P; Ware CF; Vandenabeele P; Brouckaert P
    J Biol Chem; 2001 Oct; 276(40):37426-30. PubMed ID: 11448951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A trimeric structural fusion of an antagonistic tumor necrosis factor-α mutant enhances molecular stability and enables facile modification.
    Inoue M; Ando D; Kamada H; Taki S; Niiyama M; Mukai Y; Tadokoro T; Maenaka K; Nakayama T; Kado Y; Inoue T; Tsutsumi Y; Tsunoda SI
    J Biol Chem; 2017 Apr; 292(16):6438-6451. PubMed ID: 28235800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model complexes of tumor necrosis factor-alpha with receptors R1 and R2.
    Fu ZQ; Harrison RW; Reed C; Wu J; Xue YN; Chen MJ; Weber IT
    Protein Eng; 1995 Dec; 8(12):1233-41. PubMed ID: 8869635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.